DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

511.08 4.57 (0.90%)

REAL-TIME: Last trade at

Extended Hours: $510.01 -$1.07 (-0.21%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

REGN $511.08 0.90%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $509.50
Previous Close $506.51
Daily Range $505.29 - $512.50
52-Week Range $295.76 - $544.00
Market Cap $52.8B
P/E Ratio 163.81
Dividend (Yield) $0.00 (0.0%)
Volume 374,932
Average Daily Volume 764,914
Current FY EPS $7.81

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Why Avalanche Biotechnologies, Inc. Stock Collapsed Today

Avalanche Biotechnologies saw its share price plummet today on exceptional volume. Here's why.

Is Avalanche Biotechnologies A Good Buy Now After Phase 2 Results For Its Wet AMD Drug?

IBB, CELG, AMGN, REGN: Large Inflows Detected at ETF

What Is Beyond Vision-Loss Blockbuster For Regeneron?

Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, TransUnion

Regeneron/Bayer's Eylea Gets Label Expansion in Japan - Analyst Blog

Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the N

Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication

Is It Time to Stop Chasing Netflix Higher?

Regeneron's Growth Governed By 3 Key Prospects

3 Stocks Advancing The Health Care Sector

Stock Market News for June 19, 2015 - Market News

See More REGN News...

REGN's Top Competitors

REGN $511.08 (0.90%)
Current stock: REGN
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
BIIB $404.28 (-0.28%)
Current stock: BIIB